Human Immunodeficiency Virus HIV Serum
HIV Serum - Human serum samples collected from clinically confirmed HIV donors. Ideal for antibody detection, serological assay development, and understanding disease progression and immune activation.
| Lot # | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 73460 | HIV | 1.0 ML | Hispanic/Latino | 52 | Male | United States |
biktarvy 50-200-25 MG daily
|
4 | $316.00 | |
| 72469 | HIV | 1.0 ML | Caucasian | 40 | Female | United States |
Biktarvy 25mg QD
|
4 | $316.00 | |
| 71936 | HIV | 1.0 ML | Caucasian | 45 | Male | United States |
Biktarvy 50mg/200mg/25mg QD Wellbutrin 300mg QD Adderall 10mg QD lamictal 10mg QD Biosil 105mg BID Hair Supplement QD
|
6 | $316.00 | |
| 68985 | HIV | 1.0 ML | Hispanic/Latino | 46 | Male | United States |
10mg atorvastatin 1x/day Genvoya 3in1 1x/day Estradiol Valerate 0.2 ml injection 1/week progesterone 2 100mg @ night; 15 days on 15 days off
|
6 | $316.00 | |
| 66246 | HIV | 1.0 ML | Caucasian | 65 | Male | United States |
Biktarvy Statin Tamsulosin Olanzapine
|
6 | $316.00 | |
| 68179 | HIV | 1.0 ML | African American | 45 | Male | United States |
Cabenuva injection q2 months
|
6 | $316.00 | |
| 64557 | HIV | 1.0 ML | Hispanic/Latino | 38 | Male | United States |
Biktarvy 50/200/25 mg
|
4 | $316.00 | |
| 65954 | HIV | 1.0 ML | Caucasian Asian/Pacific Islander | 44 | Female | United States |
Biktarvy Hydrochlorothiazide
|
4 | $316.00 | |
| 64207 | HIV | 1.0 ML | Caucasian | 64 | Male | United States |
Biktarvy
|
4 | $316.00 | |
| 64391 | HIV | 1.0 ML | African American | 36 | Male | United States |
Triumeq / 600-50-300 mg tablet / QD Linzess 145 mcg
|
4 | $316.00 |
HIV Serum for Research
Our Human Immunodeficiency Virus (HIV) Serum is sourced from IRB-consented donors clinically diagnosed with HIV. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for serological and immunological studies.
Serum or Plasma for HIV Work?
- Serum (this page) — the matrix for antibody work: HIV-1/2 antibody screening, confirmatory assays, seroconversion panels, and avidity testing
- Plasma — the matrix for viral load and molecular work: HIV-1 RNA quantification, genotyping, and drug resistance testing
Donor Stratification Available
- Antibody status — HIV-1 and HIV-2 reactivity, with confirmatory results where available
- Treatment status — treatment-naive or on ART
- CD4+ T cell count where recorded
- Seroconversion series — sequential draws across seroconversion where collected
- Co-infections — hepatitis B, hepatitis C, tuberculosis
- Matched seronegative controls available
Product Features
- Collected from clinically confirmed HIV donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
- Custom aliquot volumes available on request
- Defined-reactivity samples available for assay calibration
De-identified Donor Data
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
Applications
- HIV antibody screening and confirmatory assay development
- Fourth-generation combined antigen/antibody assay validation
- Seroconversion and avidity panel preparation
- Biomarker discovery for HIV
- Chronic immune activation and inflammation research
- Serum cytokine and protein profiling
- Therapeutic candidate screening and validation
Other HIV Specimen Types
Matched material from HIV-positive donors is available as HIV plasma, whole blood, PBMC, CD3+ T cells, leukopak, and bulk apheresis plasma.
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
HIV serum is available in standard and custom volumes. For pricing, international orders, or documentation requirements, please email learnmore@sanguinebio.com — infectious material shipping requires additional documentation in many jurisdictions. For the full specimen range, see our human serum collection.
Protocols & Documentation
-
Download
Serum Isolation
Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Serum
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Serum cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.